Friday - March 29, 2024
Clinical Trial Tests Efficacy of Anti-Inflammatory Drug to Treat People With COVID-19: NYU Langone Health
April 16, 2020
NEW YORK, April 16 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:

A new clinical trial seeks to determine whether the common anti-inflammatory medication colchicine can help decrease the progression of disease in people with coronavirus disease 2019 (COVID-19).

Co-led by clinician-researchers at NYU Langone Health and the Montreal Heart Institute Research Centre, the new COLCORONA trial will inve . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products